Healthcare >> CEO Interviews >> December 14, 1998
JAMES T. TREACE is President, Chief Executive Officer and Chairman of the
Board of Directors of Xomed Surgical Products, Inc., Mr. Treace has 30 years
management experience in the medical device industry with emphasis in the
orthopaedic, arthroscopic and microsurgical ENT markets. His business
knowledge incorporates all areas in product development, executive
management, business turnarounds in both public and private companies, and
one start-up. During his career he has worked for the following medical
device companies: As Sr. Vice President (1966-1981) of Smith & Nephew
Richards, an orthopaedic and ENT device company. President & CEO of Linvatec
(1981-1993), the 2nd largest arthroscopic instrument company. In 1993 he and
business partner, Barry Bays formed TreBay, a micro endoscopy ENT and
orthopaedic company. In 1996 TreBay was merged into Xomed, bringing his
management team and a strong portfolio of new ENT products. In October 1996,
Xomed completed it's IPO and a secondary offering in July 1998, netting the
Company $75 million, which was used to retire debt and general corporate
purposes. Mr. Treace is currently serving on the Board of Directors of
American Medical Systems (AMS) and is a past member of the Board of Directors
of The Health Industry Manufacturers Association (HIMA). Profile
customers, those kinds of things.
Mr. Treace: Xomed was formed in 1970 as a specialized medical device
